Three of the nation’s largest pharmacies will stop selling the heartburn medication Zantac and similar generic products following a warning by the Food and Drug Administration that the drug may contain low levels of a potentially cancer-causing substance.

from MarketWatch.com - Top Stories https://ift.tt/2nYhnXQ
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2nYhnXQ
via IFTTT
Kommentare
Kommentar veröffentlichen